These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 29395543)

  • 21. Encounters with pharmaceutical sales representatives among practicing internists.
    Ferguson RP; Rhim E; Belizaire W; Egede L; Carter K; Lansdale T
    Am J Med; 1999 Aug; 107(2):149-52. PubMed ID: 10460046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Attitudes and behaviors of psychiatry residents and psychiatrists working in training institutes towards the relationship between the pharmaceutical industry and physicians].
    Gülöksüz S; Oral ET; Ulaş H
    Turk Psikiyatri Derg; 2009; 20(3):236-42. PubMed ID: 19757223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Marketing pharmaceutical products to physicians. Sales reps influence physicians' impressions of the industry.
    Creyer EH; Hrsistodoulakis I
    Mark Health Serv; 1998; 18(2):34-8. PubMed ID: 10180333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Teaching appropriate interactions with pharmaceutical company representatives: the impact of an innovative workshop on student attitudes.
    Wofford JL; Ohl CA
    BMC Med Educ; 2005 Feb; 5(1):5. PubMed ID: 15698480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of pharmaceutical promotion on prescribing decisions of general practitioners in Eastern Turkey.
    Vancelik S; Beyhun NE; Acemoglu H; Calikoglu O
    BMC Public Health; 2007 Jun; 7():122. PubMed ID: 17592644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of Medical Representatives on Prescribing Practices in Mekelle, Northern Ethiopia.
    Workneh BD; Gebrehiwot MG; Bayo TA; Gidey MT; Belay YB; Tesfaye DM; Kassa TT
    PLoS One; 2016; 11(6):e0156795. PubMed ID: 27304215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interactions between doctors and pharmaceutical sales representatives in a former communist country. The ethical issues.
    Makowska M
    Camb Q Healthc Ethics; 2014 Jul; 23(3):349-55. PubMed ID: 24865182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Doctors and detailers: therapeutic education or pharmaceutical promotion?
    Lexchin J
    Int J Health Serv; 1989; 19(4):663-79. PubMed ID: 2583883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of Pharmaceutical Company Engagement Activities on the Decision to Prescribe: A Pilot Survey of UK Rare Disease Medicine Prescribers.
    Jandhyala R
    Pharmaceut Med; 2020 Apr; 34(2):127-134. PubMed ID: 32048216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. National survey on the attitudes of Canadian physicians towards drug-detailing by pharmaceutical representatives.
    Strang D; Gagnon M; Molloy W; Bedard M; Darzins P; Etchells E; Davidson W
    Ann R Coll Physicians Surg Can; 1996 Dec; 29(8):474-8. PubMed ID: 12380577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulating Information or Allowing Deception? Pharmaceutical Sales Visits in Canada, France, and the United States.
    Habibi R; Guénette L; Lexchin J; Reynolds E; Wiktorowicz M; Mintzes B
    J Law Med Ethics; 2016 Dec; 44(4):602-613. PubMed ID: 28661249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perceptions of the provision of drug information, pharmaceutical detailing and engagement with non-personal promotion at a large physicians network: a mixed-methods study.
    Hincapie A; Schlosser E; Damachi U; Neff E; Llambi L; Groves K; MacKinnon NJ
    BMJ Open; 2021 Jan; 11(1):e041098. PubMed ID: 33462098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. International variation in prescribing antihypertensive drugs: its extent and possible explanations.
    Fretheim A; Oxman AD
    BMC Health Serv Res; 2005 Mar; 5(1):21. PubMed ID: 15762983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What information do physicians receive from pharmaceutical representatives?
    Lexchin J
    Can Fam Physician; 1997 May; 43():941-5. PubMed ID: 9154366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influences of drug companies' advertising programs on physicians.
    Güldal D; Semin S
    Int J Health Serv; 2000; 30(3):585-95. PubMed ID: 11109183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns and clerks.
    Hodges B
    CMAJ; 1995 Sep; 153(5):553-9. PubMed ID: 7641153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Newly admitted psychiatric patient prescriptions and pharmaceutical sales visits.
    Schwartz TL; Kuhles DJ; Wade M; Masand PS
    Ann Clin Psychiatry; 2001 Sep; 13(3):159-62. PubMed ID: 11791954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The accuracy of drug information from pharmaceutical sales representatives.
    Ziegler MG; Lew P; Singer BC
    JAMA; 1995 Apr; 273(16):1296-8. PubMed ID: 7715044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics of primary health care units with focus on drug information from the pharmaceutical industry and adherence to prescribing objectives: a cross-sectional study.
    Carlzon D; Gustafsson L; Eriksson AL; Rignér K; Sundström A; Wallerstedt SM
    BMC Clin Pharmacol; 2010 Feb; 10():4. PubMed ID: 20156362
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.